Skip to content
20-F

Annual Report (Foreign)

AVRICORE HEALTH INC. AVCRF

0001493152-24-023571

← back to feed
Filed
Jun 12, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Dec 31, 2023 99.64M sh
Total Liabilities FY 2023 · Dec 31, 2022 604.89K
Current Assets FY 2023 · Dec 31, 2022 1.43M
Total Assets FY 2023 · Dec 31, 2022 2.57M
Shares Diluted FY 2023 · Dec 31, 2021 92.61M sh
Operating Cash Flow FY 2023 · Dec 31, 2021 −1.23M
Eps Diluted FY 2023 · Dec 31, 2021 −0.02
Eps Basic FY 2023 · Dec 31, 2021 −0.02
Gross Profit FY 2023 · Dec 31, 2021 30.52K
Cost Of Revenue FY 2023 · Dec 31, 2021 92.29K
Cash And Equivalents FY 2023 · Dec 31, 2020 302.72K
Stockholders Equity restated FY 2023 · Dec 31, 2020 −724.04K